Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3343584 | Best Practice & Research Clinical Rheumatology | 2008 | 16 Pages |
Abstract
Osteogenesis Imperfecta is a heritable disorder characterized by bone fragility and low bone mass, with a wide spectrum of clinical expression. This review gives an update on its classification, the recent developments in the understanding of its pathophysiological mechanisms, and the current status of bisphosphonate therapy. Other therapeutic approaches and future directions of research are briefly discussed.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Francis H. Glorieux,